16-88717172-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM5BP4BS2
The NM_001142864.4(PIEZO1):c.6511G>A(p.Val2171Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000645 in 1,550,544 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2171F) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001142864.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIEZO1 | NM_001142864.4 | c.6511G>A | p.Val2171Ile | missense_variant | 45/51 | ENST00000301015.14 | NP_001136336.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIEZO1 | ENST00000301015.14 | c.6511G>A | p.Val2171Ile | missense_variant | 45/51 | 1 | NM_001142864.4 | ENSP00000301015.9 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000128 AC: 2AN: 156668Hom.: 0 AF XY: 0.0000121 AC XY: 1AN XY: 82888
GnomAD4 exome AF: 0.00000644 AC: 9AN: 1398314Hom.: 0 Cov.: 35 AF XY: 0.00000725 AC XY: 5AN XY: 689574
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2023 | The c.6511G>A (p.V2171I) alteration is located in exon 45 (coding exon 45) of the PIEZO1 gene. This alteration results from a G to A substitution at nucleotide position 6511, causing the valine (V) at amino acid position 2171 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at